A chief executive officer (CEO) is the highest officer charged with the management of an organization – especially a company or nonprofit institution.
AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Aviva plc is a British multinational insurance company headquartered in London, England. It has about 18 million customers across its core markets of the United Kingdom, Ireland and Canada. In the United Kingdom, Aviva is the largest general insurer and a leading life and pensions provider. Aviva is also the second largest general insurer in Canada.
Thierry Breton is a French business executive, politician, writer and the current Commissioner for Internal Market of the European Union. Breton was vice-chairman and CEO of Groupe Bull (1996–1997), chairman and CEO of Thomson-RCA (1997–2002) and chairman and CEO of France Télécom (2002–2005). In 2005 he entered politics serving as Minister of Economy, Finance and Industry (2005–2007) in the governments of Prime Ministers Jean-Pierre Raffarin and Dominique de Villepin, during the presidency of Jacques Chirac. From 2007 to 2008 he was a professor at Harvard Business School before joining group Atos from 2009 to 2019 as its CEO.
Louis Schweitzer is a Swiss businessman who is a former chairman of the board of Groupe Renault, first taking the post on 27 May 1992, succeeding Raymond Lévy. He was also CEO from 1992 to 2005. He was in addition Chairman of AstraZeneca until 8 June 2012 where he was appointed as a Director on 11 March 2004. He is a non-executive director of BNP Paribas, Electricité de France, Veolia Environnement, Volvo AB and L'Oréal, and Vice-Chairman of the Supervisory Board of Philips Electronics NV
Sir Thomas Fulton Wilson McKillop, FRS, FRSE is a Scottish chemist, who was CEO of AstraZeneca PLC from 1999 until 2006 and chairman of the RBS Group from 2006 until 2008.
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Ian Graham King is a British businessman who was the CEO of BAE Systems from 2008 to 2017. Until 20 June 2014 he was a non-executive director of Rotork plc. He is currently Chairman of Senior plc.
Andrew N. Liveris is an Australian former CEO and chairman of The Dow Chemical Company of Midland, Michigan. Liveris served as a member of Dow's board of directors since February 2004, CEO since November 2004 and was elected as chairman of the board effective 1 April 2006. Liveris became CEO in 2004 after holding the position of chief operating officer (COO). Afterwards he served as executive chairman of DowDuPont. He is chairman of the board of Lucid Motors.
Amylin Pharmaceuticals, Inc. is a biopharmaceutical founded in 1987 that was based in San Diego, California. The company was engaged in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, and other diseases. Amylin produced three drugs: Symlin, Byetta (exenatide) and Bydureon.
Sir Menelaos (Mene) Nicolas Pangalos is a British neuroscientist of Greek descent.
Michael D. Fascitelli is an American businessman. He is a member of the Vornado Realty Trust board of trustees and former CEO and president of the company before stepping down from day-to-day responsibilities on February 26, 2013. He is a co-owner of the Milwaukee Bucks, and in 2017 founded a $500 million SPAC, Landscape Acquisitions, with Noam Gottesman where they both serve as co-chairman. Since stepping back from day-to-day responsibilities at Vornado, Fascitelli has formed MDF Capital, a family-office investment firm, Landscape Acquisitions, a hospitality and real estate focused SPAC, and Imperial Companies. He serves on the board of real estate technology startup Cadre.
Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.
Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.
Joseph Jimenez is the former CEO of the Swiss pharmaceutical company Novartis.
Sherilyn S. McCoy is an American scientist and business executive. She is the former CEO of Avon Products and former vice chairman and member of the office of the chairman of Johnson & Johnson, where she was responsible for the pharmaceutical and consumer business divisions of the company. She was appointed as the vice chairman in January 2011, after which she was named by Fortune Magazine, as the 10th woman on their list of "50 Most Powerful Women in Business", a list on which she has been included since 2008. In February 2012, she resigned her employment with Johnson & Johnson after 30 years and was subsequently named as the CEO of Avon Products. In August 2012, she was recognized as the 39th most powerful woman in the world by Forbes Magazine.
Sir Pascal Claude Roland Soriot is a French-born Australian businessman and chief executive officer (CEO) of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.
Angus C. Russell is a British businessman. He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013.
Thomas Buberl is a German businessman who has been the CEO of Axa since 2016.
Paul Hudson is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.
